Penney McWilliams-Koeppen

Scientist, Discovery Research at Rampart Bioscience

Penney McWilliams-Koeppen is a skilled Scientist with extensive experience in discovery research, currently leading non-viral gene therapy initiatives at Rampart Bioscience. McWilliams-Koeppen develops strategies for treating inherited metabolic disorders and has established an iPSC-derived hepatocyte platform to enhance non-viral DNA product development. Previous roles include Associate Scientist, where screening of LNP-encapsulated DNA was conducted, and Senior Research Associate, focusing on optimizing lentiviral vector transduction protocols. Additional experience includes research in T cell therapeutics at City of Hope and significant roles at ATCC and the University of Tennessee, coupled with a strong educational background in Infectious Diseases and Microbiology from the University of Pittsburgh and a degree in Biological Sciences from Goucher College.

Links

Previous companies

ATCC logo
City of Hope logo


Teams

This person is not in any teams